Sculptor Capital’s Senti Biosciences Holdings SNTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-4,668
Closed -$15.2M – 1203
2022
Q1
$15.2M Hold
4,668
– – 0.12% 145
2021
Q4
$15.2M Buy
4,668
+4,096
+716% +$13.5M 0.13% 123
2021
Q3
$1.88M Hold
572
– – 0.02% 492
2021
Q2
$1.88M Buy
+572
New +$1.88M 0.01% 530

Other funds holding SNTI

Sculptor Capital's SNTI Position: Q2 2022 in Review

Sculptor Capital sold out of Senti Biosciences Holdings (SNTI) in Q2 2022, closing a stake of 4,668 shares — an estimated $15.2M sold.

Sculptor Capital first reported a position in SNTI in Q2 2021 and held it in 4 quarters. The position peaked at $15.2M in Q1 2022. 20 funds tracked by Wall St. Rank hold SNTI as of Q2 2022.

  • Sculptor Capital reported no remaining Senti Biosciences Holdings position as of Q2 2022 after selling out during the quarter.
  • Sculptor Capital sold 4,668 Senti Biosciences Holdings shares in Q2 2022, an estimated $15.2M.
  • Sculptor Capital first reported a position in Senti Biosciences Holdings in Q2 2021 and held it in 4 quarters.
  • Sculptor Capital's Senti Biosciences Holdings position peaked at $15.2M in Q1 2022.
  • 20 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q2 2022.

Based on Sculptor Capital's 13F filing for Q2 2022, filed 12 Aug 2022.